Cilobamine
![]() | |
| Clinical data | |
|---|---|
| ATC code | none |
| Identifiers | |
| |
| CAS Number | 69429-84-1 |
| PubChem (CID) | 299379 |
| ChemSpider | 8557262 |
| UNII |
067U1T4S30 |
| ChEMBL | CHEMBL2106470 |
| Chemical and physical data | |
| Formula | C17H23Cl2NO |
| Molar mass | 328.27662 g/mol |
| 3D model (Jmol) | Interactive image |
| |
Cilobamine is a drug which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and has stimulant and antidepressant effects.[1][2]
It can clearly be seen that the structure is based on dichloroisoprenaline that has been fused onto the bicycloalkane scaffold.
See also
References
- ↑ Leeson GA, Shaath ZA, Biedenbach SA, Yarrington JT, Okerholm RA. Dose related induction of the drug metabolizing enzymes of rat liver by cilobamine. Fundamental and Applied Toxicology. 1984 Apr;4(2 Pt 1):261-9. PMID 6724198
- ↑ Wager, S.; Quitkin, F.; Stewart, J.; McGrath, P.; Harrison, W.; Markowitz, J.; Tricamo, E. (1988). "Cilobamine in the treatment of atypical depression". Human Psychopharmacology: Clinical and Experimental. 3 (3): 201. doi:10.1002/hup.470030308.
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| α1 |
| ||||||
|---|---|---|---|---|---|---|---|
| α2 |
| ||||||
| β |
| ||||||
| |||||||
| D1-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the 5/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
